684 related articles for article (PubMed ID: 32497804)
1. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
2. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
[TBL] [Abstract][Full Text] [Related]
3. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting adherence to antiretroviral therapy among children and adolescents living with HIV in the Mbita Sub-County Hospital, Homa Bay- Kenya.
Tanyi WN; Gachuno O; Odero T; Farquhar C; Kimosop D; Mayi A
Afr Health Sci; 2021 May; 21(Suppl):18-24. PubMed ID: 34447419
[TBL] [Abstract][Full Text] [Related]
5. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
[TBL] [Abstract][Full Text] [Related]
6. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
[TBL] [Abstract][Full Text] [Related]
7. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
[TBL] [Abstract][Full Text] [Related]
8. Clinic-level and individual-level factors that influence HIV viral suppression in adolescents and young adults: a national survey in Kenya.
Njuguna I; Neary J; Mburu C; Black D; Beima-Sofie K; Wagner AD; Mugo C; Evans Y; Guthrie B; Itindi J; Onyango A; Oyiengo L; Richardson BA; Wamalwa D; John-Stewart G
AIDS; 2020 Jun; 34(7):1065-1074. PubMed ID: 32287060
[TBL] [Abstract][Full Text] [Related]
9. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
[TBL] [Abstract][Full Text] [Related]
10. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
[TBL] [Abstract][Full Text] [Related]
11. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
12. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
Opoku S; Sakyi SA; Ayisi-Boateng NK; Enimil AK; Senu E; Ansah RO; Aning BD; Ojuang DA; Wekesa DN; Ahmed FO; Okeke CB; Sarfo AD
AIDS Res Ther; 2022 May; 19(1):21. PubMed ID: 35614510
[TBL] [Abstract][Full Text] [Related]
14. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
[TBL] [Abstract][Full Text] [Related]
15. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
[TBL] [Abstract][Full Text] [Related]
16. Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting.
Lumu I; Musaazi J; Castelnuovo B
AIDS; 2022 Nov; 36(13):1791-1800. PubMed ID: 35876663
[TBL] [Abstract][Full Text] [Related]
17. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
[TBL] [Abstract][Full Text] [Related]
18. Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018.
Ali JH; Yirtaw TG
BMC Infect Dis; 2019 Dec; 19(1):1084. PubMed ID: 31881859
[TBL] [Abstract][Full Text] [Related]
19. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Holloway J; Johnson M; Phillips AN
HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression.
Smith CJ; Phillips AN; Dauer B; Johnson MA; Lampe FC; Youle MS; Tyrer M; Staszewski S
HIV Med; 2009 Jan; 10(1):19-27. PubMed ID: 19018880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
